Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 213025

In scope icon L 4 A
QID 213025 (Type "213025" in App Search)
A 51-year-old woman presents with a polyostotic condition resulting in the lesions shown in Figure A. If malignant transformation were to occur, histology would show which of the following (Figures B through E)?
  • A
  • B
  • C
  • D
  • E
  • F

Figure B

8%

181/2391

Figure C

14%

323/2391

Figure D

47%

1116/2391

Figure E

19%

464/2391

Figure F

11%

273/2391

  • A
  • B
  • C
  • D
  • E
  • F

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

The lesions present in this patient are consistent with a diagnosis of multiple hereditary exostosis (MHE). In patients with MHE, there is a 10% risk of malignant transformation to chondrosarcoma. Figure D demonstrates histopathology consistent with a low-grade chondrosarcoma.

MHE is an autosomal dominant disorder characterized by the development of multiple skeletal osteochondromas. This disease process results from mutations in the EXT-1, EXT-2, and EXT-3 tumor suppressor genes. Patients with the EXT-1 mutation have the greatest disease severity and as a result the highest risk of malignant transformation. Although the resulting osteochondromas can appear at any location associated with a physis, the lesions typically occur in the distal femur, proximal tibia, proximal femur, and proximal humerus.

Czajka et al. investigated the proportion of patients undergoing malignant transformation among a large international, heterogeneous cohort of patients with MHE. They reported a 2.7% rate of malignant degeneration, at a mean age of 28.6 years and reported that the most common sites of malignant change from benign exostoses were the pelvis and scapula. The authors concluded that MHE is a progressive disease associated with an ongoing risk of chondrosarcoma, and therefore patients with this diagnosis should be monitored regularly throughout their lifetime.

Sonne-Holm et al. published a systematic review on MHE and the development of chondrosarcoma. They reported that there is a wide range in the frequency (1-25%) of malignant transition of MHE into sarcomas, and that the exostoses in the axial skeleton are more prone to develop into chondrosarcomas than peripheral exostoses. They recommend a screening program be launched with clinical examination by MR imaging or bone scintigraphy every two years for surveillance.

Figures:
Figure A depicts a sessile osteochondroma of the left proximal humerus, proximal tibia and fibula.
Figure B, C, D, E, and F depict the histological sections of chrondromyxoid fibroma, osteochondroma, chondrosarcoma, osteosarcoma, and synovial sarcoma, respectively.

Incorrect Answers:
Answer 1: Figure B depicts a chondromyxoid fibroma, with the typical stellate-shaped cells within a myxoid stroma. These lesions are not associated with MHE.
Answer 2: Figure C is the histology of a benign osteochondroma, demonstrating a large benign-appearing cartilage cap and underlying osseous element.
Answer 4: Figure E is a histological section of an osteosarcoma. There are characteristic atypical spindle cells with high nuclear-to-cytoplasm ratio associated with lacey osteoid. MHE patients are more likely to undergo malignant transformation of existing osteochondromas into chondrosarcoma.
Answer 5: Figure F depicts histology consistent with a synovial sarcoma. There is a classic biphasic pattern of spindle and epithelial cells. MHE patients are more likely to develop chondrosarcoma.

REFERENCES (2)
Authors
Rating
Please Rate Question Quality

3.9

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(7)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options